Brian Beachler
Family Medicine · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Brian Beachler’s office at (510) 981-4100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A174284 · Current
Licensed to practise in California · since 2021 · expires 2027-08-31 · Lewis Katz School of Medicine at Temple University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Medicaid work
$336,814 in 2024
Medicaid paid $336,814 for 3,676 billed services this clinician did in 2024, up to 109 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,182 | $251,354 |
| Return visit (30+ min) | 674 | $39,316 |
| Short return visit (20+ min) | 865 | $35,743 |
| Short return visit | 339 | $5,500 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 281 | $2,217 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 40 | $761 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 23 | $676 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 32 | $432 |
| Long return visit (40+ min) | 19 | $366 |
| Screening test, pure tone, air only | 42 | $275 |
| HEMOGLOBIN | 179 | $176 |
| 2024 | 3,676 | 11 | 109 | $336,814 |
| 2023 | 4,552 | 12 | 132 | $281,323 |
| 2022 | 5,568 | 17 | 187 | $301,051 |
| 2021 | 1,537 | 12 | 130 | $74,058 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,223 | $249,118 |
| Return visit (30+ min) | 688 | $12,003 |
| Short return visit (20+ min) | 622 | $7,310 |
| Long return visit (40+ min) | 226 | $4,685 |
| Short return visit | 512 | $2,971 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 136 | $1,609 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 461 | $1,038 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 48 | $785 |
| Screening test, pure tone, air only | 162 | $731 |
| Developmental screening | 30 | $675 |
| HEMOGLOBIN | 430 | $397 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 14 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,324 | $265,782 |
| Return visit (30+ min) | 1,015 | $15,802 |
| Short return visit (20+ min) | 689 | $7,752 |
| Short return visit | 472 | $3,261 |
| Long return visit (40+ min) | 85 | $2,364 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 106 | $1,661 |
| Screening test, pure tone, air only | 244 | $1,157 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 699 | $1,076 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 50 | $921 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 63 | $510 |
| HEMOGLOBIN | 494 | $454 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 26 | $255 |
2021
| Clinic visit/encounter, all-inclusive | 330 | $66,487 |
| Return visit (30+ min) | 201 | $2,950 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 59 | $796 |
| Short return visit | 95 | $729 |
| Short return visit (20+ min) | 82 | $728 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 45 | $566 |
| Service | 12 | $516 |
| Screening test, pure tone, air only | 106 | $456 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 277 | $370 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 142 | $326 |
| HEMOGLOBIN | 164 | $113 |
| Bilateral quantitative screening test of visual acuity | 24 | $21 |
Drugs they prescribed that Part D paid
$218,198
Pharmacies billed $218,198 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (38 of 1,548) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,250 generic and 282 brand-name prescriptions · $218,198 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 40 | $51,203 | $1,280 |
| Ozempic | 41 | $37,584 | $917 |
| Xarelto | 12 | $7,229 | $602 |
| Lidocaine | 13 | $2,228 | $171 |
| Albuterol Sulfate Hfa | 30 | $1,256 | $42 |
See all 39 drugs
| Jardiance | 40 | $51,203 | $1,280 |
| Ozempic | 41 | $37,584 | $917 |
| Xarelto | 12 | $7,229 | $602 |
| Lidocaine | 13 | $2,228 | $171 |
| Albuterol Sulfate Hfa | 30 | $1,256 | $42 |
| Hydrocodone-Acetaminophen | 27 | $805 | $30 |
| Buprenorphine-Naloxone | 13 | $661 | $51 |
| Valsartan | 19 | $618 | $33 |
| Famotidine | 41 | $589 | $14 |
| Atorvastatin | 136 | $581 | $4 |
| Diclofenac | 12 | $562 | $47 |
| Propranolol | 24 | $536 | $22 |
| Tamsulosin | 30 | $458 | $15 |
| Hydroxyzine | 18 | $449 | $25 |
| Omeprazole | 30 | $399 | $13 |
| Duloxetine | 22 | $390 | $18 |
| Levothyroxine | 25 | $376 | $15 |
| Metformin | 54 | $373 | $7 |
| Gabapentin | 30 | $357 | $12 |
| Trazodone | 16 | $317 | $20 |
| Carvedilol | 29 | $277 | $10 |
| Pantoprazole | 19 | $265 | $14 |
| Fluticasone Propionate | 24 | $258 | $11 |
| Oxycodone-Acetaminophen | 11 | $250 | $23 |
| Simvastatin | 25 | $197 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $190 | $15 |
| Metoprolol | 22 | $189 | $9 |
| Lisinopril | 55 | $169 | $3 |
| Sertraline | 22 | $146 | $7 |
| Clonidine | 11 | $139 | $13 |
| Zolpidem | 20 | $123 | $6 |
| Amlodipine Besylate | 53 | $121 | $2 |
| Losartan | 34 | $106 | $3 |
| Hydrochlorothiazide | 42 | $91 | $2 |
| Prednisone | 11 | $72 | $7 |
| Pregabalin | 11 | $59 | $5 |
| Alendronate | 19 | $55 | $3 |
| Lisinopril-Hydrochlorothiazide | 12 | $44 | $4 |
| Ibuprofen | 12 | $40 | $3 |
Year by year
| 2024 | 1,548 | 116 | 3% (38) | 18% | $218,198 |
| 2023 | 1,120 | 100 | 3% (37) | 15% | $158,024 |
| 2022 | 701 | 85 | 2% (13) | None | $96,707 |
| 2021 | 337 | 60 | 0% (0) | None | $20,222 |
| 2020 | 352 | 68 | None | None | $22,183 |
| 2019 | 179 | 40 | None | 28% | $17,341 |
| 2018 | 14 | None | 0% (0) | None | $2,085 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Jardiance | 25 | $32,739 | $1,310 |
| Trulicity | 12 | $21,967 | $1,831 |
| Symbicort | 14 | $8,637 | $617 |
| Dexlansoprazole Dr | 12 | $6,257 | $521 |
| Diclofenac | 32 | $3,740 | $117 |
| Atorvastatin | 85 | $2,631 | $31 |
| Ventolin Hfa | 20 | $1,242 | $62 |
| Amlodipine Besylate | 56 | $1,094 | $20 |
| Lisinopril | 57 | $840 | $15 |
| Gabapentin | 27 | $738 | $27 |
| Metformin | 50 | $736 | $15 |
| Albuterol Sulfate Hfa | 18 | $722 | $40 |
| Duloxetine | 20 | $618 | $31 |
| Losartan | 34 | $601 | $18 |
| Hydrocodone-Acetaminophen | 24 | $586 | $24 |
| Propranolol | 16 | $509 | $32 |
| Sertraline | 19 | $491 | $26 |
| Hydrochlorothiazide | 27 | $441 | $16 |
| Omeprazole | 26 | $426 | $16 |
| Carvedilol | 21 | $421 | $20 |
| Pantoprazole | 13 | $409 | $31 |
| Levothyroxine | 20 | $395 | $20 |
| Metoprolol | 22 | $365 | $17 |
| Tamsulosin | 11 | $363 | $33 |
| Fluticasone Propionate | 21 | $312 | $15 |
| Alendronate | 13 | $252 | $19 |
| Famotidine | 11 | $244 | $22 |
| Simvastatin | 22 | $225 | $10 |
| Fluoxetine | 12 | $204 | $17 |
| Pregabalin | 11 | $173 | $16 |
| Naproxen | 12 | $155 | $13 |
| Diazepam | 13 | $50 | $4 |
2022: 20 drugs
| Jardiance | 21 | $20,198 | $962 |
| Symbicort | 14 | $6,996 | $500 |
| Diclofenac | 26 | $1,306 | $50 |
| Gabapentin | 25 | $631 | $25 |
| Atorvastatin | 39 | $569 | $15 |
| Losartan | 24 | $469 | $20 |
| Lisinopril | 39 | $458 | $12 |
| Duloxetine | 16 | $454 | $28 |
| Amlodipine Besylate | 43 | $403 | $9 |
| Metformin | 33 | $365 | $11 |
| Omeprazole | 26 | $347 | $13 |
| Sertraline | 12 | $245 | $20 |
| Carvedilol | 14 | $243 | $17 |
| Hydrochlorothiazide | 15 | $235 | $16 |
| Metoprolol | 12 | $208 | $17 |
| Simvastatin | 12 | $172 | $14 |
| Fluticasone Propionate | 18 | $165 | $9 |
| Famotidine | 13 | $135 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $124 | $8 |
| Ibuprofen | 18 | $77 | $4 |
2021: 9 drugs
| Ventolin Hfa | 13 | $765 | $59 |
| Albuterol Sulfate Hfa | 13 | $577 | $44 |
| Atorvastatin | 21 | $256 | $12 |
| Levothyroxine | 14 | $190 | $14 |
| Lisinopril | 30 | $188 | $6 |
| Metformin | 21 | $167 | $8 |
| Losartan | 19 | $162 | $9 |
| Amlodipine Besylate | 11 | $134 | $12 |
| Gabapentin | 13 | $109 | $8 |
2020: 9 drugs
| Albuterol Sulfate Hfa | 16 | $738 | $46 |
| Atorvastatin | 28 | $275 | $10 |
| Omeprazole | 11 | $162 | $15 |
| Metformin | 15 | $135 | $9 |
| Lisinopril | 16 | $114 | $7 |
| Amlodipine Besylate | 12 | $88 | $7 |
| Gabapentin | 18 | $84 | $5 |
| Acyclovir | 11 | $51 | $5 |
| Simvastatin | 13 | $34 | $3 |
2019: 1 drug
| Ranitidine | 15 | $151 | $10 |
Money from drug and device companies
$18 in 2024
| 2024 | 1 | 1 | None | $18 |
| 2023 | 3 | 3 | None | $60 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Mounjaro | $18 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2024-01-25 | Mounjaro | $18 |
See earlier years (2023)
2023: $60
| Organon | Nexplanon | $25 | 1 payment
|
| Novo Nordisk | Wegovy | $20 | 1 payment
|
| Lilly USA | Emgality | $15 | 1 payment
|
Professional record
- NPI
- 1043715816
- Licence
- CA A174284California A174284: Current · expires 2027-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 150 Harbour Way, Richmond, CA, 94801
- NPI first listed
- 2018-03-26
- NPI last updated
- 2026-08-13
- NPI record certified
- 2026-08-13
This is when the NPI record was last certified, not a medical board exam.